Activity to Breast Cancer Cell Lines of Different Malignancy and Predicted Interaction with Protein Kinase C Isoforms of Royleanones
Open Access
- 23 May 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (10), 3671
- https://doi.org/10.3390/ijms21103671
Abstract
Plants have been used for centuries to treat several illnesses. The Plectranthus genus has a vast variety of species that has allowed the isolation of cytotoxic compounds with notable activities. The abietane diterpenes 6,7-dehydroroyleanone (DeRoy, 1), 7α-acetoxy-6β-hydroxyroyleanone (Roy, 2), and Parvifloron D (ParvD, 3) were obtained from Plectranthus spp. and showed promising biological activities, such as cytotoxicity. The inhibitory effects of the different natural abietanes (1-3) were compared in MFC7, SkBr3, and SUM159 cell lines, as well as SUM159 grown in cancer stem cell-inducing conditions. Based on the royleanones’ bioactivity, the derivatives RoyBz (4), RoyBzCl (5), RoyPr2 (6), and DihydroxyRoy (7), previously obtained from 2, were selected for further studies. Protein kinases C (PKCs) are involved in several carcinogenic processes. Thus, PKCs are potential targets for cancer therapy. To date, the portfolio of available PKC modulators remains very limited due to the difficulty of designing isozyme-selective PKC modulators. As such, molecular docking was used to evaluate royleanones 1-6 as predicted isozyme-selective PKC binders. Subtle changes in the binding site of each PKC isoform change the predicted interaction profiles of the ligands. Subtle changes in royleanone substitution patterns, such as a double substitution only with non-substituted phenyls, or hydroxybenzoate at position four that flips the binding mode of ParvD (3), can increase the predicted interactions in certain PKC subtypes.Keywords
Funding Information
- Haridus- ja Teadusministeerium (IUT34-14)
- Fundação para a Ciência e a Tecnologia (UID/DTP/04567/2019, UID/QUI/50006/2020 and grants CBIOS/PRUID/BI1/2017 and SFRH/BD/137671/2018., PT2020 UID/MULTI/04378/2013 and the project (3599-PPCDT) PTDC/DTP-FTO/1981/2014 – POCI-01-0145-FEDER-016581)
- European Regional Development Fund (POCI/01/0145/FEDER/007728)
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (173001)
This publication has 44 references indexed in Scilit:
- New Natural Diterpene-Type Abietane from Tetradenia riparia Essential Oil with Cytotoxic and Antioxidant ActivitiesMolecules, 2014
- Antiproliferative Activity of Abietane Diterpenoids against Human Tumor CellsJournal of Natural Products, 2013
- Adenosine-binding motif mimicry and cellular effects of a thieno[2,3-d]pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymesBiochemical Journal, 2013
- Protein Kinase C Regulates Human Pluripotent Stem Cell Self-RenewalPLOS ONE, 2013
- microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase CɛOncogene, 2011
- Plectranthus: A plant for the future?South African Journal of Botany, 2011
- Protein Kinase C: An Attractive Target for Cancer TherapyCancers, 2011
- Structural Basis of Protein Kinase C Isoform FunctionPhysiological Reviews, 2008
- Centrosomal PKCβII and Pericentrin Are Critical for Human Prostate Cancer Growth and AngiogenesisCancer Research, 2008
- Clustal W and Clustal X version 2.0Bioinformatics, 2007